Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FJH70
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,678
Award facts
- Contract value 100% obligated
- $38,677.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,677.92 to AmerisourceBergen Drug Corp for Actemra ActPen 162 mg/0.9 mL auto-injectors. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used primarily in the treatment of rheumatoid arthritis and other inflammatory conditions, making this delivery order part of the company's ongoing pharmaceutical supply chain support to federal medical systems.
This delivery order is a child contract executed under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving the Defense Health Agency and other federal healthcare systems, AmerisourceBergen maintains a substantial portfolio of competitively awarded delivery orders with DLA across multiple therapeutic domains. The company's established role as a critical vendor in the federal medical supply chain enables efficient fulfillment of urgent pharmaceutical needs such as this single-day delivery order for specialty medications supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FJH70?
SPE2DB25FJH70 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FJH70 worth?
The government has obligated $38,678 on SPE2DB25FJH70.
Is contract SPE2DB25FJH70 an order under another contract?
Yes. SPE2DB25FJH70 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJH70 competed?
The extent of competition for SPE2DB25FJH70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award